Tower Research Capital (TRC)’s Leverage Shares 2X Long AAL Daily ETF AALG Stock Holding History

Tower Research Capital (TRC)’s Portfolio AALG Stock Details AALG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29	Closed	-$514	–	5731
2025 Q4	$514	Buy	+29	New	+$421	﹤0.01%	4884

Other funds holding AALG

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s AALG Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Leverage Shares 2X Long AAL Daily ETF (AALG) in Q1 2026, closing a stake of 29 shares — an estimated $514 sold.

Tower Research Capital (TRC) first reported a position in AALG in Q4 2025 and held it in 1 quarter. The position peaked at $514 in Q4 2025. 3 funds tracked by Wall St. Rank hold AALG as of Q1 2026.

Tower Research Capital (TRC) reported no remaining Leverage Shares 2X Long AAL Daily ETF position as of Q1 2026 after selling out during the quarter.
Tower Research Capital (TRC) sold 29 Leverage Shares 2X Long AAL Daily ETF shares in Q1 2026, an estimated $514.
Tower Research Capital (TRC) first reported a position in Leverage Shares 2X Long AAL Daily ETF in Q4 2025 and held it in 1 quarter.
Tower Research Capital (TRC)'s Leverage Shares 2X Long AAL Daily ETF position peaked at $514 in Q4 2025.
3 funds tracked by Wall St. Rank held Leverage Shares 2X Long AAL Daily ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.